Arrowhead Pharmaceuticals, Inc.
ARWR
$15.93
$0.130.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 110.27% | 158.15% | 71.19% | -2.23% | 8.30% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 115.65% | -10.94% | 8.22% | -8.42% | 10.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 41.83% | -44.05% | -29.00% | -55.86% | -32.71% |
| Total Current Assets | 109.59% | 139.82% | 66.99% | -4.28% | -5.77% |
|
|
|||||
| Total Current Assets | 109.59% | 139.82% | 66.99% | -4.28% | -5.77% |
| Net Property, Plant & Equipment | 6.28% | 14.17% | 28.53% | 54.48% | 78.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -18.07% | -17.28% | -16.57% | -15.91% | -15.30% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 524.76% | 1,228.88% | 37.53% | 2,023.81% | 0.00% |
| Total Assets | 64.74% | 61.86% | 48.89% | 11.05% | 7.16% |
|
|
|||||
| Total Accounts Payable | 17.12% | 224.15% | -68.25% | 237.19% | -10.83% |
| Total Accrued Expenses | 117.56% | 54.46% | 84.97% | 33.22% | 22.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,258.22% | 139.26% | -39.96% | 114.42% | 94.95% |
| Total Finance Division Other Current Liabilities | 462.31% | -74.35% | -69.78% | -56.66% | -80.02% |
| Total Other Current Liabilities | 462.31% | -74.35% | -69.78% | -56.66% | -80.02% |
| Total Current Liabilities | 238.38% | 47.13% | -2.17% | 37.72% | -25.22% |
|
|
|||||
| Total Current Liabilities | 238.38% | 47.13% | -2.17% | 37.72% | -25.22% |
| Long-Term Debt | 99.76% | 175.70% | 173.75% | 27.74% | 8.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.37% | -5.09% | 6.14% | 40.21% | 41.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 93.43% | 111.59% | 98.32% | 31.63% | 7.87% |
|
|
|||||
| Common Stock & APIC | 19.11% | 39.87% | 38.88% | 39.40% | 40.35% |
| Retained Earnings | -11.21% | -55.20% | -58.43% | -58.78% | -57.88% |
| Treasury Stock & Other | 500.91% | 429.64% | 247.42% | -140.15% | -229.82% |
| Total Common Equity | 41.24% | -67.22% | -31.66% | -9.40% | 8.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.24% | -67.22% | -31.66% | -9.40% | 8.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -92.21% | -73.80% | -64.48% | -50.88% | -36.67% |
| Total Equity | 38.11% | -67.72% | -33.47% | -11.26% | 6.51% |
|
|
|||||